Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients
NCT02399579 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2015-07-02
Summary
The purpose of this study is to better standardize the symptom recording of cat allergic persons under real-life conditions. A new self-assessed, home-based symptom score will be tested.
Conditions
- Cat Allergy
Interventions
- OTHER
-
Provocation test
The participants will perform 8 provocation tests. Every provocation test consists of petting the cat until the participants become symptomatic. The symptoms of cat allergic participants with the cat owner's cat will be recorded before and after petting the cat.
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Thomas M. Kündig, PD Dr. med. · University of Zurich
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
NCT07315945 ·Status: RECRUITING
-
Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration
NCT00457444 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
NCT06960382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients
NCT03850626 ·Status: COMPLETED
-
Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy
NCT07110311 ·Status: RECRUITING
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA
-
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01144429 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
NCT04981717 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration
NCT00719511 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study About Sensitization Pattern to Insects as Food Source in Patients With House Dust Mite Allergy
NCT04239131 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
NCT03509766 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
NCT03436797 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge
NCT03838731 ·Status: COMPLETED ·Phase: PHASE2
-
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595 ·Status: COMPLETED ·Phase: PHASE3
-
Exposure Chamber Trial With Cat Immunotherapy
NCT00987909 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients
NCT04673591 ·Status: COMPLETED ·Phase: PHASE2
-
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999 ·Status: COMPLETED
-
Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
NCT00362999 ·Status: COMPLETED
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA